Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 10 | History Defined

Women Battle On For Equality In Top Business Jobs

More women are taking top management jobs but inequality persists, with men still dominating business leadership roles, research showed ahead of International Women's Day on March 8.

International Business Times · Mar 5, 2024

Safety fears over asthma drug after young children suffer severe side effects

Campaigners call for more warnings on montelukast, after reports of night terrors, depression and other mental health events

The Guardian - UK · Mar 3, 2024

20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

International Business Times · Feb 28, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

50 Top Companies By Market Capitalization: The Global Giants

These companies are the ones that dominate the market and will continue to do so should factors remain constant.

International Business Times · Feb 27, 2024

Rachel Nuwer: MDMA Is On the Cusp of Legalization

In 2024, the FDA will decide whether or not MDMA can be used to treat patients suffering from PTSD.

Reason · Feb 7, 2024

Merck (MRK): Quarterly Earnings - What Investors Should Know

Pharma giant Merck (MRK) has an impressive record of surpassing analysts’ expectations in its top and bottom lines. So, is the company on track to top estimates in the upcoming earnings release? Let’s discuss some of its financials to gauge its prospects.

StockNews.com · Jan 31, 2024

Merck, Johnson & Johnson CEOs agree to appear before Senate HELP - Roll Call

Two drug company CEOs have agreed to testify before the Senate HELP Committee on drug prices, avoiding a scheduled subpoena vote on Jan. 31.

Roll Call · Jan 26, 2024

Read news from The Economist, FT, and more,
with one subscription

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Kiplinger · Jan 18, 2024

Cyberwar continues to underperform

Episode 487 of the Cyberlaw Podcast

Reason · Jan 17, 2024

Merck Hooks Harpoon Therapeutics in 0M Acquisition Spree!

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

3 Pharma Stock Buys for Last-Minute Year-End Profits

Growing healthcare spending and the use of cutting-edge technologies in the research and development of new drugs have put the pharmaceutical industry in a strong position for growth. With such constructive trends in mind, it's wise to buy fundamentally strong pharma stocks, Merck (MRK), Collegium (COLL) and Johnson & Johnson…

StockNews.com · Dec 26, 2023

Looking back on the challenges CEOs faced in 2023, from war to climate change to the A.I. boom

Looking ahead, 2024 likely will be filled with volatility, uncertainty, complexity, and ambiguity. That’s "VUCA" for you.

Fortune · Dec 20, 2023

Are These 3 Pharma Stocks Smart Buys for Bullish Investors?

The pharmaceutical industry's outlook looks promising, given robust healthcare spending worldwide and the rapid adoption of advanced digital technologies. Amid this, let’s find out if pharma stocks AbbVie (ABBV), Collegium Pharmaceutical (COLL), and Merck (MRK) are ideal buys now. Read on to know more….

StockNews.com · Dec 18, 2023

Analyzing Pharma Stock Giants: JNJ, MRK, and ABBV

The pharmaceutical industry is set for long-term growth due to growing demand for quality drugs and therapies, an aging population, and the rise in lifestyle-related diseases. Now, let's explore the investment potential of industry giants Merck & Co (MRK), Johnson & Johnson (JNJ), and AbbVie (ABBV). Keep reading.

StockNews.com · Nov 15, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune · Nov 9, 2023

Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics

Plus: Frazier talks about the shareholders who trusted his vision enough to support him in his early days at the helm.

Barchart · Nov 9, 2023

The 3 Best Dow Jones Stocks to Invest in Now, According to Wall Street

Analysts are bullish on these three dividend-paying Dow stocks, with consensus "Strong Buy" ratings and more upside expected for this diverse set of blue chips.

Fortune · Nov 9, 2023

Ex-Merck CEO Ken Frazier says CEOs must uphold American values

Frazier was one of the first CEOs to publicly distance himself from President Donald Trump.

The Independent UK · Oct 27, 2023

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Oct 7, 2023

3 Beaten-Down Dow Stocks to Buy in October

Dow Jones industrials, such as Nike, have pulled back significantly amid recent market turmoil, and now trade at a steep discount to consensus price target estimates.

WEKU · Oct 4, 2023

All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

Fortune · Oct 3, 2023

Former Merck boss Ken Frazier wants CEOs to speak out

In a politicized world, the former Merck boss says CEOs should stand up and speak out. “Pick your spots.”

Barchart · Sep 28, 2023

How To Buy MRK For A 5% Discount, Or Achieve An 13% Annual Return

Yesterday, with Merck trading at $103.94, the November put option with a strike price of $100 was trading around $1.78. Traders selling this put would receive $178 in option premium.

Salon · Sep 23, 2023

Amy Klobuchar on Biden's biggest win

Minnesota senator and anti-monopoly crusader explains how fixing Medicare's drug problem will help everybody

Fortune · Sep 13, 2023

Managers say they support skills-based hiring. But many jobs still require 4-year degrees

Just over half of hiring managers say removing four-year degree requirements would positively impact their company's hiring practices, according to a OneTen report.

The Guardian - US · Aug 29, 2023

Biden names 10 drugs for first negotiations to cut Medicare prices

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional

1 … 9 10 11 12

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.